BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28504839)

  • 1. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
    Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
    FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.
    Fra AM; Gooptu B; Ferrarotti I; Miranda E; Scabini R; Ronzoni R; Benini F; Corda L; Medicina D; Luisetti M; Schiaffonati L
    PLoS One; 2012; 7(6):e38405. PubMed ID: 22723858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs.
    Tumpara S; Ballmaier M; Wrenger S; König M; Lehmann M; Lichtinghagen R; Martinez-Delgado B; Korenbaum E; DeLuca D; Jedicke N; Welte T; Fromme M; Strnad P; Stolk J; Janciauskiene S
    Elife; 2021 May; 10():. PubMed ID: 34002692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency Variant.
    Ronzoni R; Ferrarotti I; D'Acunto E; Balderacchi AM; Ottaviani S; Lomas DA; Irving JA; Miranda E; Fra A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α
    Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
    Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.
    Mahadeva R; Dafforn TR; Carrell RW; Lomas DA
    J Biol Chem; 2002 Mar; 277(9):6771-4. PubMed ID: 11773044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization.
    Haq I; Irving JA; Saleh AD; Dron L; Regan-Mochrie GL; Motamedi-Shad N; Hurst JR; Gooptu B; Lomas DA
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):71-80. PubMed ID: 26091018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
    Núñez A; Belmonte I; Miranda E; Barrecheguren M; Farago G; Loeb E; Pons M; Rodríguez-Frías F; Gabriel-Medina P; Rodríguez E; Genescà J; Miravitlles M; Esquinas C
    Respir Res; 2021 Sep; 22(1):244. PubMed ID: 34526035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
    Callea F; Giovannoni I; Francalanci P; Boldrini R; Faa G; Medicina D; Nobili V; Desmet VJ; Ishak K; Seyama K; Bellacchio E
    Orphanet J Rare Dis; 2018 May; 13(1):79. PubMed ID: 29769092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
    Kueppers F; Andrake MD; Xu Q; Dunbrack RL; Kim J; Sanders CL
    BMC Med Genet; 2019 Jul; 20(1):125. PubMed ID: 31307431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants.
    Ronzoni R; Berardelli R; Medicina D; Sitia R; Gooptu B; Fra AM
    Hum Mol Genet; 2016 Feb; 25(4):642-50. PubMed ID: 26647313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.
    Belmonte I; Barrecheguren M; López-Martínez RM; Esquinas C; Rodríguez E; Miravitlles M; Rodríguez-Frías F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2535-2541. PubMed ID: 27877030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.
    Miranda E; Pérez J; Ekeowa UI; Hadzic N; Kalsheker N; Gooptu B; Portmann B; Belorgey D; Hill M; Chambers S; Teckman J; Alexander GJ; Marciniak SJ; Lomas DA
    Hepatology; 2010 Sep; 52(3):1078-88. PubMed ID: 20583215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution ex vivo NMR spectroscopy of human Z α
    Jagger AM; Waudby CA; Irving JA; Christodoulou J; Lomas DA
    Nat Commun; 2020 Dec; 11(1):6371. PubMed ID: 33311470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
    Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the site encoded by SERPINA1*E342K for treating alpha-1 antitrypsin deficiency-associated liver diseases.
    Zhang X; Pham K; Li D; Schutte RJ; Brantly M; Liu C; Ostrov DA
    FEBS Lett; 2019 Jul; 593(14):1849-1862. PubMed ID: 31116417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
    Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
    Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.